Overview

Post-Operative Nausea And Vomiting Study In Female Patients

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine an effective dose of this NK-1 anti-emetic medication to prevent nausea and vomiting in females after surgery.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Casopitant
Neurokinin-1 Receptor Antagonists